Fate Therapeutics Grants New Hires 300,000 Stock Options, 87,000 Restricted Stock Units
Bitget2026/11/03 21:20- Fate Therapeutics granted non-qualified stock options covering 300,000 shares to one newly hired non-executive employee on November 2, 2026.
- Restricted stock units covering 87,000 shares went to two newly hired non-executive employees, including the option recipient.
- Options vest 25% on the grant's first anniversary, with the remaining 75% in approximately equal monthly installments over 36 months.
- RSUs vest 25% on each grant anniversary over four years. All awards require continuous employment through each vesting date.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny
CoreWeave will release its third-quarter financial report. Whether it can demonstrate that its rapid revenue growth is sufficient to cover the rising financing costs and construction expenditures will directly determine the direction of market confidence.
Crypto prices
More
